{"component": "definition", "props": {"groups": [{"snippet": "means the Party or Parties undertaking development and exploitation pursuant to Clauses 11 and 12;", "size": 6, "samples": [{"hash": "jLgejHPlKLW", "uri": "/contracts/jLgejHPlKLW#exploiting-party", "label": "Agreement for the Provision of Funding", "score": 33.2237981578, "published": true}, {"hash": "kgs2Hcpy1Ih", "uri": "/contracts/kgs2Hcpy1Ih#exploiting-party", "label": "Agreement for the Provision of Funding (PTC Therapeutics, Inc.)", "score": 22.370294319, "published": true}, {"hash": "6kK4la9KIk4", "uri": "/contracts/6kK4la9KIk4#exploiting-party", "label": "Agreement for the Provision of Funding (PTC Therapeutics, Inc.)", "score": 22.370294319, "published": true}], "snippet_links": [{"key": "party-or-parties", "type": "definition", "offset": [10, 26]}, {"key": "development-and-exploitation", "type": "clause", "offset": [39, 67]}, {"key": "clauses-11", "type": "clause", "offset": [80, 90]}], "hash": "5a6ec96e23abb6ff87136ee1da32a3a5", "id": 1}, {"snippet": "means whichever of the Grantee or Technology Transfer Group (if any) as applicable will be responsible for the Exploitation of the Grant Funded IP for and on behalf of the Grantee.", "size": 3, "samples": [{"hash": "jPVDRW07BOj", "uri": "https://rnid.org.uk/wp-content/uploads/2021/03/Discovery-Research-Grant-standard-terms-and-conditions.pdf", "label": "rnid.org.uk", "score": 10.5646817248, "published": false}, {"hash": "3I6XH9ynpr4", "uri": "https://rnid.org.uk/wp-content/uploads/2020/09/Fellowship-Grant-standard-terms-and-conditions.pdf", "label": "rnid.org.uk", "score": 10.3429158111, "published": false}, {"hash": "8nMNYpRPrW2", "uri": "https://rnid.org.uk/wp-content/uploads/2020/06/Discovery-Research-Grant-standard-terms-and-conditions.pdf", "label": "rnid.org.uk", "score": 10.0102669405, "published": false}], "snippet_links": [{"key": "the-grantee", "type": "clause", "offset": [19, 30]}, {"key": "technology-transfer", "type": "definition", "offset": [34, 53]}, {"key": "responsible-for", "type": "clause", "offset": [91, 106]}, {"key": "grant-funded-ip", "type": "definition", "offset": [131, 146]}, {"key": "for-and-on-behalf-of", "type": "clause", "offset": [147, 167]}], "hash": "df0fdcfb7e8cba6287c6f7f281288e2e", "id": 2}, {"snippet": "means the Party responsible for commercialising and exploiting the Project Intellectual Property with or without the Background Intellectual Property in accordance with Clause 7 ;", "size": 2, "samples": [{"hash": "hYqSxPVR6kT", "uri": "/contracts/hYqSxPVR6kT#exploiting-party", "label": "Award Agreement", "score": 23.5749486653, "published": true}, {"hash": "iF3O64opQs9", "uri": "https://www.bhf.org.uk/-/media/files/research/bhf-translational-research-award-terms--conditions---final.doc", "label": "www.bhf.org.uk", "score": 9.4236824093, "published": false}], "snippet_links": [{"key": "responsible-for", "type": "clause", "offset": [16, 31]}, {"key": "project-intellectual-property", "type": "definition", "offset": [67, 96]}, {"key": "background-intellectual-property", "type": "definition", "offset": [117, 149]}, {"key": "in-accordance-with", "type": "definition", "offset": [150, 168]}, {"key": "clause-7", "type": "definition", "offset": [169, 177]}], "hash": "190de595f18ab3be840e2df0f05698d8", "id": 3}, {"snippet": "means the Party(ies) undertaking Exploitation pursuant to Clauses 5 and 16. For clarity any Third Party to whom the Company or its Affiliates licences the Exploitation of the Exploitation IPRs shall not be considered an Exploiting Party for the purposes of this Agreement;", "size": 2, "samples": [{"hash": "cWrmxbxkpgV", "uri": "/contracts/cWrmxbxkpgV#exploiting-party", "label": "Translation Award Funding Agreement (Summit Therapeutics PLC)", "score": 24.1553730322, "published": true}, {"hash": "5uM49iaOAnQ", "uri": "/contracts/5uM49iaOAnQ#exploiting-party", "label": "Translation Award Funding Agreement (Summit Corp PLC)", "score": 23.9226557153, "published": true}], "snippet_links": [{"key": "clauses-5", "type": "clause", "offset": [58, 67]}, {"key": "for-clarity", "type": "clause", "offset": [76, 87]}, {"key": "third-party", "type": "clause", "offset": [92, 103]}, {"key": "the-company", "type": "definition", "offset": [112, 123]}, {"key": "for-the-purposes-of-this-agreement", "type": "clause", "offset": [237, 271]}], "hash": "0f6ecafe6230b11db7f29c3714669371", "id": 4}, {"snippet": "means whichever of the Organisation or Technology Transfer Group (if there is one) named above as is or will be responsible for technology transfer and commercialisation matters with respect to the Trust-funded Project for and on behalf of the Organisation. For these purposes, \u2018exploitation\u2019 includes but is not limited to commercialization by way of licence, assignment, option, sale, research collaboration or other agreement, or for cash or equity consideration. \u2018Grant\u2019 means the grant, details of which are set out in Schedule 1 to this Agreement. \u2018Gross Income\u2019 means all cash sums or other monetary consideration actually received in respect of exploitation of the Trust-funded Project, including licence, signing and option fees, royalties, and milestones, but excludes any Equity or other interests (whether by way of debenture, warrant, security or otherwise) or monies paid specifically to fund the undertaking of a research programme. \u2018Organisation\u2019 means the organisation named in the details set out above. \u2018Intellectual Property\u2019 means any and all rights in inventions, discoveries, materials, technologies, products, data, algorithms, software, know-how, patents, databases, copyright, trademarks, design rights, applications for any of the foregoing, moral rights, and any other intellectual property rights whether or not registered or capable of registration and whether or not subsisting in the UK or in any other part of the world.", "size": 1, "samples": [{"hash": "64KzGgYxzf5", "uri": "/contracts/64KzGgYxzf5#exploiting-party", "label": "Profit Sharing Agreement", "score": 30.2324103055, "published": true}], "snippet_links": [{"key": "the-organisation", "type": "clause", "offset": [19, 35]}, {"key": "technology-transfer", "type": "definition", "offset": [39, 58]}, {"key": "responsible-for", "type": "clause", "offset": [112, 127]}, {"key": "to-the-trust", "type": "definition", "offset": [191, 203]}, {"key": "funded-project", "type": "clause", "offset": [204, 218]}, {"key": "for-and-on-behalf-of", "type": "clause", "offset": [219, 239]}, {"key": "not-limited", "type": "clause", "offset": [309, 320]}, {"key": "research-collaboration", "type": "clause", "offset": [387, 409]}, {"key": "other-agreement", "type": "definition", "offset": [413, 428]}, {"key": "for-cash", "type": "definition", "offset": [433, 441]}, {"key": "equity-consideration", "type": "clause", "offset": [445, 465]}, {"key": "the-grant", "type": "definition", "offset": [481, 490]}, {"key": "details-of", "type": "clause", "offset": [492, 502]}, {"key": "set-out", "type": "definition", "offset": [513, 520]}, {"key": "schedule-1", "type": "definition", "offset": [524, 534]}, {"key": "to-this-agreement", "type": "clause", "offset": [535, 552]}, {"key": "gross-income", "type": "definition", "offset": [555, 567]}, {"key": "monetary-consideration", "type": "clause", "offset": [598, 620]}, {"key": "in-respect-of", "type": "clause", "offset": [639, 652]}, {"key": "of-the-trust", "type": "clause", "offset": [666, 678]}, {"key": "option-fees", "type": "definition", "offset": [726, 737]}, {"key": "other-interests", "type": "definition", "offset": [793, 808]}, {"key": "to-fund", "type": "definition", "offset": [899, 906]}, {"key": "the-undertaking", "type": "clause", "offset": [907, 922]}, {"key": "research-programme", "type": "clause", "offset": [928, 946]}, {"key": "rights-in-inventions", "type": "clause", "offset": [1064, 1084]}, {"key": "design-rights", "type": "definition", "offset": [1215, 1228]}, {"key": "applications-for", "type": "clause", "offset": [1230, 1246]}, {"key": "the-foregoing", "type": "definition", "offset": [1254, 1267]}, {"key": "moral-rights", "type": "clause", "offset": [1269, 1281]}, {"key": "other-intellectual-property-rights", "type": "clause", "offset": [1291, 1325]}, {"key": "not-registered", "type": "clause", "offset": [1337, 1351]}, {"key": "capable-of", "type": "definition", "offset": [1355, 1365]}, {"key": "the-world", "type": "definition", "offset": [1443, 1452]}], "hash": "fa76583b5655ffe6e3b1a2f7da312e16", "id": 5}, {"snippet": "means whichever of the Institution or Technology Transfer Group (if there is one) as is or will be responsible for technology transfer and commercialisation matters with respect to the Project funded by The Charity for and on behalf of the Institution. For these purposes, \u2018exploitation\u2019 includes but is not limited to commercialization by way of licence, assignment, option, sale, research collaboration or other agreement, or for cash or equity consideration.", "size": 1, "samples": [{"hash": "gLu54FAFb2b", "uri": "https://assets.thebraintumourcharity.org/live/media/filer_public/53/b9/53b9f0f4-c079-47a5-acd0-7d656fbea128/terms_and_conditions_of_award_for_research_grants_v8_24042015.pdf", "label": "assets.thebraintumourcharity.org", "score": 7.8884325804, "published": false}], "snippet_links": [{"key": "the-institution", "type": "clause", "offset": [19, 34]}, {"key": "technology-transfer", "type": "definition", "offset": [38, 57]}, {"key": "responsible-for", "type": "clause", "offset": [99, 114]}, {"key": "with-respect-to", "type": "clause", "offset": [165, 180]}, {"key": "the-project", "type": "definition", "offset": [181, 192]}, {"key": "for-and-on-behalf-of", "type": "clause", "offset": [215, 235]}, {"key": "not-limited", "type": "clause", "offset": [304, 315]}, {"key": "research-collaboration", "type": "clause", "offset": [382, 404]}, {"key": "other-agreement", "type": "definition", "offset": [408, 423]}, {"key": "for-cash", "type": "definition", "offset": [428, 436]}, {"key": "equity-consideration", "type": "clause", "offset": [440, 460]}], "hash": "0f397eaa427e7bc8855eb84fd0fb6779", "id": 6}, {"snippet": "means the commercial industry party or parties, or other organisations who are identified and appointed by A-WOL for the international registration, manufacture, supply, distribution and sale of the Product in accordance with the Global Access Plan and the Charitable Objectives;", "size": 1, "samples": [{"hash": "gF15Fn31Ymb", "uri": "/contracts/gF15Fn31Ymb#exploiting-party", "label": "Consortium Agreement (Combinatorx, Inc)", "score": 19.0, "published": true}], "snippet_links": [{"key": "party-or-parties", "type": "definition", "offset": [30, 46]}, {"key": "international-registration", "type": "clause", "offset": [121, 147]}, {"key": "sale-of-the-product", "type": "clause", "offset": [187, 206]}, {"key": "in-accordance-with", "type": "definition", "offset": [207, 225]}, {"key": "access-plan", "type": "clause", "offset": [237, 248]}], "hash": "bc51f8f95f26417a9d6d8f17180209f7", "id": 7}, {"snippet": "The Exploiting Party is the EIT Food Partner that will take the primary responsibility for the commercial Exploitation of the Results of the KAVA. The EIT Food Partners working together in the KAVA should make arrangements between themselves in order to determine who will be the Exploiting Party towards KIC LE. Since EIT Food Partners are deemed to enter into a consortium agreement, the expectation is that these arrangements will be made at the level of the consortium agreement. When an Exploiting Party would leave the consortium, the overall arrangements regarding further execution of the KAVA when EIT Food Partners are leaving (see Art. 32 of the MGA) will apply. Typically, the tasks will be reallocated, appropriate amendments will have to be made. Also, this Agreement would have to be amended in the event of a change of parties involved.", "size": 1, "samples": [{"hash": "1pbAQh1Zcfq", "uri": "/contracts/1pbAQh1Zcfq#exploiting-party", "label": "Revenue Sharing Mechanism Agreement", "score": 32.8428971439, "published": true}], "snippet_links": [{"key": "responsibility-for", "type": "clause", "offset": [72, 90]}, {"key": "results-of-the", "type": "clause", "offset": [126, 140]}, {"key": "working-together", "type": "definition", "offset": [169, 185]}, {"key": "to-determine", "type": "clause", "offset": [251, 263]}, {"key": "to-enter", "type": "definition", "offset": [348, 356]}, {"key": "consortium-agreement", "type": "definition", "offset": [364, 384]}, {"key": "the-consortium", "type": "definition", "offset": [458, 472]}, {"key": "further-execution", "type": "clause", "offset": [572, 589]}, {"key": "this-agreement", "type": "clause", "offset": [767, 781]}, {"key": "parties-involved", "type": "definition", "offset": [835, 851]}], "hash": "c9f64713edfe5cc47c478e8eb35df891", "id": 8}, {"snippet": "means whichever of the Institution or Technology Transfer Group (if there is one) named above as is or will be responsible for technology transfer and commercialisation matters with respect to the Trust-funded Project for and on behalf of the Institution. For these purposes, \u2018exploitation\u2019 includes but is not limited to commercialization by way of licence, assignment, option, sale, research collaboration or other agreement, or for cash or equity consideration.", "size": 1, "samples": [{"hash": "dj0uWxB9Giz", "uri": "/contracts/dj0uWxB9Giz#exploiting-party", "label": "Exploitation Consent and Revenue/Equity Sharing Agreement", "score": 29.3399497255, "published": true}], "snippet_links": [{"key": "the-institution", "type": "clause", "offset": [19, 34]}, {"key": "technology-transfer", "type": "definition", "offset": [38, 57]}, {"key": "responsible-for", "type": "clause", "offset": [111, 126]}, {"key": "to-the-trust", "type": "definition", "offset": [190, 202]}, {"key": "funded-project", "type": "clause", "offset": [203, 217]}, {"key": "for-and-on-behalf-of", "type": "clause", "offset": [218, 238]}, {"key": "not-limited", "type": "clause", "offset": [307, 318]}, {"key": "research-collaboration", "type": "clause", "offset": [385, 407]}, {"key": "other-agreement", "type": "definition", "offset": [411, 426]}, {"key": "for-cash", "type": "definition", "offset": [431, 439]}, {"key": "equity-consideration", "type": "clause", "offset": [443, 463]}], "hash": "5b807d34b3e2ffd80a203b1465c9a13e", "id": 9}, {"snippet": "shall have the meaning set forth in Section 2.15.5.", "size": 1, "samples": [{"hash": "3A4XwA0s2rj", "uri": "/contracts/3A4XwA0s2rj#exploiting-party", "label": "Research Collaboration and License Agreement (BCTG Acquisition Corp.)", "score": 32.4579055441, "published": true}], "snippet_links": [], "hash": "91bac2a28cf661801081b75ca3175851", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZZXhwbG9pdGluZy1wYXJ0eSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Exploiting Party", "snippet": "means the Party or Parties undertaking development and exploitation pursuant to Clauses 11 and 12;", "size": 24, "id": "exploiting-party", "examples": ["Notwithstanding the above, the Parties acknowledge and agree that if the Non-<strong>Exploiting Party</strong> can reasonably demonstrate that any aspect of the Key Product Strategy proposed by the <strong>Exploiting Party</strong> will materially prejudice the Exploitation of any Product(s) which have been launched, the <strong>Exploiting Party</strong> will not proceed with such aspect of the Key Product Strategy.", "All sums due to Diabetes UK under this clause 3 shall be paid by the <strong>Exploiting Party</strong> to DUKSL, which shall fulfil the <strong>Exploiting Party</strong>\u2019s payment obligations towards Diabetes UK under this clause 3.", "The <strong>Exploiting Party</strong> shall send to DUKSL the appropriate payments required in respect of such statements within 14 (fourteen) days of receipt of the proper VAT invoice(s) from DUKSL.", "The <strong>Exploiting Party</strong> shall provide the Other Party(s) with copies of supporting financial documentation on reasonable request.", "The <strong>Exploiting Party</strong> agrees that it or the relevant licensee shall be solely responsible, at their own cost, for all such payments to Third Parties and any amounts payable to the other Parties under this Agreement shall not be reduced as a consequence except as explicitly provided in Schedule 6.", "The <strong>Exploiting Party</strong> shall keep the Non-<strong>Exploiting Party</strong> informed regarding the Key Product Strategy for each Product and take into account the reasonable recommendations of the Non-<strong>Exploiting Party</strong> relating to such Key Product Strategy.", "IP To the extent that the exploitation of any Project IP owned by a Party (the \u201c<strong>Exploiting Party</strong>\u201d) depended on the use of the other Party\u2019s Background IP, such other Party would, subject to any existing third-party obligations, grant to the <strong>Exploiting Party</strong> a non-exclusive licence to that Background IP on fair and reasonable terms to be agreed in writing by the Parties.", "The <strong>Exploiting Party</strong> shall keep accurate records and accounts, and the Other Party(s) shall have the right to audit these in accordance with standard UK accounting practice on request.", "Within three (3) months following the annual accounting date set out in Schedule 2 the <strong>Exploiting Party</strong> shall provide to DUKSL a statement or statements setting out financial information for the preceding 12 month period ending on such annual accounting date in respect of each Grant Funded Intellectual Property commercialised, including Gross Revenue, Net Revenue, Direct Costs Equity, any applicable taxes on Gross Income and Direct Costs plus the share of revenues due to Diabetes UK.", "The <strong>Exploiting Party</strong> shall send to the Other Party(s) the appropriate payments required in respect of such statements within thirty (30) days of receipt of the proper VAT invoice(s)."], "related": [["licensed-know-how", "Licensed Know-How", "Licensed Know-How"], ["licensor", "Licensor", "Licensor"], ["licensee", "Licensee", "Licensee"], ["collaboration-know-how", "Collaboration Know-How", "Collaboration Know-How"], ["the-licensee", "the Licensee", "the Licensee"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}